Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

QCI — Predicate Candidate Screening

9 FDA 510(k) clearances under this product code; the 50 most recent screened below.

286 daysmedian FDA review time
329 days90th percentile
9clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K243459Ultimate rTMS for OCD (M-series)Brain Ultimate, Inc.2025-04-171600
K230657BTL-99-OCBTL Industries, Inc.2024-02-013290
K233742CloudTMS Edge for OCDTeleemg, LLC2023-12-22300
K231350OCD MT Cap (85-00397-000)Neuronetics2023-06-08300
K221129CloudTMS for OCDTeleemg, LLC2023-03-103260
K212289NeuroStar Advanced Therapy for adjunctive treatment of OCD, Neuronetics, Inc.2022-05-062890
K193006MagVenture TMS Therapy – for treatment of OCD, MagVenture TMTonica Elektronik A/S2020-08-092860
K183303Brainsway Deep TMS SystemBrainsway , Ltd.2019-03-081010
DEN170078Brainsway Deep Transcranial Magnetic Stimulation (DTMS) SystBrainways , Ltd.2018-08-173220

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda